Zdrowie i gospodarka · 08/06/1995
FDA Announces Response to Citizen Petition on Patent Term Extensions Under Uruguay Round Agreements Act
The US Food and Drug Administration (FDA) has released its response to a petition from Glaxo Pharmaceuticals, Inc. regarding the impact of the Uruguay Round Agreements Act (URAA) on patent term extensions for human and animal drug products.